RE: BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER–GENITO-URINARY GROUP PHASE III TRIAL (30906)

Autor: Mehraban, Darab, Esfahani, Fatemeh
Zdroj: In The Journal of Urology 2005 174(3):1151-1151
Databáze: ScienceDirect